|Videos|December 20, 2019
Management of HER2 Expression in Breast Cancer
Author(s)Sponsored Content
Ian E. Krop, MD, PhD, provides insight on HER2 expression in breast cancer, treatment for blocking HER2, and the management of newly diagnosed HER2+ metastatic breast cancer with T-DM1.
Advertisement
Ian E. Krop, MD, PhD, provides insight on HER2 expression in breast cancer, treatment for blocking HER2, and the management of newly diagnosed HER2+ metastatic breast cancer with T-DM1.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
A Story of Staying Active After a Lung Cancer Diagnosis
2
FDA Designates MB-105 to Speed Review for Relapsed T-Cell Lymphoma
3
Emerging Treatments and Hopeful Advances in Pancreatic Cancer
4
Signatera Guides Bladder Cancer Treatment After Surgery
5
